Docon Technologies Private Ltd, the promoter and holding company of diagnostic chain Thyrocare has sold 1,57,69,696 Thyrocare shares, representing around 9.90 per cent of the company’s paid-up equity capital, through market trades.
No articles in the last 24 hours. Expand to 1 week
